Use of corticosteroids in asthma and COPD patients with or without COVID-19

The potential detrimental effects of steroids on the immune system to fight viral infections had always been a concern for patients on long term steroids in chronic conditions. A recent warning from WHO on systemic corticosteroid use amid COVID-19 raised suspicion among public and healthcare profess...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasan, Syed Shahzad, Capstick, Toby, Zaidi, Syed Tabish Razi, Kow, Chia Siang, Merchant, Hamid A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255263/
https://www.ncbi.nlm.nih.gov/pubmed/32843175
http://dx.doi.org/10.1016/j.rmed.2020.106045
_version_ 1783539701506899968
author Hasan, Syed Shahzad
Capstick, Toby
Zaidi, Syed Tabish Razi
Kow, Chia Siang
Merchant, Hamid A.
author_facet Hasan, Syed Shahzad
Capstick, Toby
Zaidi, Syed Tabish Razi
Kow, Chia Siang
Merchant, Hamid A.
author_sort Hasan, Syed Shahzad
collection PubMed
description The potential detrimental effects of steroids on the immune system to fight viral infections had always been a concern for patients on long term steroids in chronic conditions. A recent warning from WHO on systemic corticosteroid use amid COVID-19 raised suspicion among public and healthcare professionals regarding the safety of steroid use during the SARS-CoV-2 pandemic. The corticosteroids (inhaled and oral) are commonly prescribed in the management of asthma and COPD patients and any unsolicited changes in medications use may lead to potentially severe exacerbations and may risk patient lives. This article provides a critical review of clinical evidence and offers a detailed discussion on the safety and efficacy of corticosteroids in asthma and COPD patients, both with and without COVID-19.
format Online
Article
Text
id pubmed-7255263
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-72552632020-05-28 Use of corticosteroids in asthma and COPD patients with or without COVID-19 Hasan, Syed Shahzad Capstick, Toby Zaidi, Syed Tabish Razi Kow, Chia Siang Merchant, Hamid A. Respir Med Review Article The potential detrimental effects of steroids on the immune system to fight viral infections had always been a concern for patients on long term steroids in chronic conditions. A recent warning from WHO on systemic corticosteroid use amid COVID-19 raised suspicion among public and healthcare professionals regarding the safety of steroid use during the SARS-CoV-2 pandemic. The corticosteroids (inhaled and oral) are commonly prescribed in the management of asthma and COPD patients and any unsolicited changes in medications use may lead to potentially severe exacerbations and may risk patient lives. This article provides a critical review of clinical evidence and offers a detailed discussion on the safety and efficacy of corticosteroids in asthma and COPD patients, both with and without COVID-19. Elsevier Ltd. 2020 2020-05-26 /pmc/articles/PMC7255263/ /pubmed/32843175 http://dx.doi.org/10.1016/j.rmed.2020.106045 Text en © 2020 Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review Article
Hasan, Syed Shahzad
Capstick, Toby
Zaidi, Syed Tabish Razi
Kow, Chia Siang
Merchant, Hamid A.
Use of corticosteroids in asthma and COPD patients with or without COVID-19
title Use of corticosteroids in asthma and COPD patients with or without COVID-19
title_full Use of corticosteroids in asthma and COPD patients with or without COVID-19
title_fullStr Use of corticosteroids in asthma and COPD patients with or without COVID-19
title_full_unstemmed Use of corticosteroids in asthma and COPD patients with or without COVID-19
title_short Use of corticosteroids in asthma and COPD patients with or without COVID-19
title_sort use of corticosteroids in asthma and copd patients with or without covid-19
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255263/
https://www.ncbi.nlm.nih.gov/pubmed/32843175
http://dx.doi.org/10.1016/j.rmed.2020.106045
work_keys_str_mv AT hasansyedshahzad useofcorticosteroidsinasthmaandcopdpatientswithorwithoutcovid19
AT capsticktoby useofcorticosteroidsinasthmaandcopdpatientswithorwithoutcovid19
AT zaidisyedtabishrazi useofcorticosteroidsinasthmaandcopdpatientswithorwithoutcovid19
AT kowchiasiang useofcorticosteroidsinasthmaandcopdpatientswithorwithoutcovid19
AT merchanthamida useofcorticosteroidsinasthmaandcopdpatientswithorwithoutcovid19

Ejemplares similares